Filter Results:
(4,965)
Show Results For
- All HBS Web
(4,965)
- People (16)
- News (1,913)
- Research (2,476)
- Events (2)
- Multimedia (221)
- Faculty Publications (1,886)
Show Results For
- All HBS Web
(4,965)
- People (16)
- News (1,913)
- Research (2,476)
- Events (2)
- Multimedia (221)
- Faculty Publications (1,886)
- Career Coach
Jessica Mbaeliachi
East and Turkey, based in the UAE. In this role she was responsible for launching innovative care delivery methods, and building long-term partnerships with an ecosystem of healthcare providers, investors and infrastructure developers.... View Details
- Student-Profile
Olivia Zhao
health has such a universal reach in their life. If you can improve the system in some way then you can have a lot of impact. I just knew I would find interesting problems by focusing my research on health... View Details
- 01 Jun 2013
- News
Lab Work
After 16 years at the Australian technology-transfer organization UniQuest, managing director David Henderson (MBA 1989) is moving on to new challenges. Looking back on the experience of shepherding technologies from the university to the marketplace—the... View Details
- April 1989
- Supplement
Novel Combination of Two Drugs (C)
Herzlinger, Regina E. "Novel Combination of Two Drugs (C)." Harvard Business School Supplement 189-170, April 1989.
- April 1989
- Supplement
Novel Combination of Two Drugs (B)
Herzlinger, Regina E. "Novel Combination of Two Drugs (B)." Harvard Business School Supplement 189-169, April 1989.
- 28 Nov 2016
- News
One Obstacle to Curing Cancer
- September 1995
- Case
Apollo Hospitals of India (B)
The Indian Hospitals Corp. (IHC), a branch of Apollo Hospitals Group, is considering building a hospital and primary-care medical center in Colombo, the capital of Sri-Lanka, a small island off the southern coast of India. This case describes economic, social, and... View Details
Loveman, Gary W., and Jamie O'Connell. "Apollo Hospitals of India (B)." Harvard Business School Case 396-028, September 1995.
- January 2005 (Revised March 2006)
- Case
Molecular Insight Pharmaceuticals, Inc.
By: Richard G. Hamermesh and Edwin W. Parkinson III
Molecular Insight has developed a novel biopharmaceutical to detect heart attacks. The company's unique approach to intellectual property protection uses the Hatch Waxman Act and the Orphan Drug Act. The company is struggling to raise $7 million in Series B financing.... View Details
Hamermesh, Richard G., and Edwin W. Parkinson III. "Molecular Insight Pharmaceuticals, Inc." Harvard Business School Case 805-067, January 2005. (Revised March 2006.)
- 16 Oct 2017
- Working Paper Summaries
Healthy Business? Managerial Education and Management in Healthcare
- 16 Nov 2021
- News
Getting Back Together for Global Networking Night; Healthcare Conference Draws New Interest
pillars of health care in terms of the sectors, so we had pharma and biotech as one group, digital and IT, Investment, and then care providers,” says HBSHAA copresident Nicki... View Details
Keywords: Margie Kelley
- August 2017
- Article
Effective Leadership of Surgical Teams: A Mixed Methods Study of Surgeon Behaviors and Functions
By: J. Stone, E. Aveling, M. Frean, M. Shields, C. Wright, F. Gino, T. Sundt and S.J. Singer
The importance of effective team leadership for achieving surgical excellence is widely accepted, but we understand less about the behaviors that achieve this goal. We studied cardiac surgical teams to identify leadership behaviors that best support surgical teamwork.... View Details
Stone, J., E. Aveling, M. Frean, M. Shields, C. Wright, F. Gino, T. Sundt, and S.J. Singer. "Effective Leadership of Surgical Teams: A Mixed Methods Study of Surgeon Behaviors and Functions." Annals of Thoracic Surgery 104, no. 2 (August 2017): 530–537.
- February 1998 (Revised April 1999)
- Case
Medical Consultants Network, Inc.
By: Paul W. Marshall and Jefferson C. Grahling
Marshall, Paul W., and Jefferson C. Grahling. "Medical Consultants Network, Inc." Harvard Business School Case 898-173, February 1998. (Revised April 1999.)
- November 2014
- Teaching Note
Claritas Genomics
By: Robert F. Higgins and Matthew G. Preble
Dr. Patrice Milos is the first CEO of Claritas Genomics (Claritas) and she faces a number of challenges in scaling the young company. Claritas was formed around a lab spun out from Boston Children's Hospital (BCH) which had performed genomic tests for the hospital. Now... View Details
- September 2022
- Article
How Emerging Telehealth Models Challenge Policymaking
By: Mitchell Tang, Michael E Chernew and Ateev Mehrotra
Policy Points
Current telehealth policy discussions are focused on synchronous video and audio telehealth visits delivered by traditional providers and have neglected the growing number of alternative telehealth offerings.
These alternative... View Details
Tang, Mitchell, Michael E Chernew, and Ateev Mehrotra. "How Emerging Telehealth Models Challenge Policymaking." Milbank Quarterly 100, no. 3 (September 2022): 650–672.
- September 2016 (Revised October 2018)
- Case
Springfield Hospital
By: Susanna Gallani and Robert Kaplan
One of the key roles of costing systems is to support the evaluation of performance and facilitate appropriate resource allocations. Through participation in a comparative cost study, management at Springfield Hospital, known for its heavy focus on operational... View Details
Keywords: Time-Driven Activity-Based Costing; Variance Analysis; Activity Based Costing and Management; Health Care and Treatment; Health Industry
Gallani, Susanna, and Robert Kaplan. "Springfield Hospital." Harvard Business School Case 117-025, September 2016. (Revised October 2018.)
- 01 Sep 2010
- News
RX for Change
employs 9,000 people and ranks as Georgia’s largest, most comprehensive health system. Under consideration this day is a proposal to add specialists — known as neurohospitalists — to manage care for patients... View Details
- 14 Apr 2021
- Research & Ideas
The High Cost of the Slow COVID Vaccine Rollout
accounting that includes health care costs puts the savings figure closer to $1.3 trillion. And capacity to produce an additional 1 billion vaccine courses could similarly be worth on the order of $1... View Details